(RTTNews) - NVIDIA (NVDA) announced plans for new collaborations with IBM and the U.S. Department of Energy's Fermi National Accelerator Laboratory that will span research into next-generation modular architectures for quantum computers. IBM and NVIDIA are colocating NVIDIA DGX B
(RTTNews) - Payment technology company Mastercard Incorporated (MA), announced the launch of Mastercard Accept, a solution that lets eligible debit and prepaid cardholders to receive digital payments directly into their existing bank accounts through their mobile banking or payme
(RTTNews) - Eisai Co., Ltd. (4523.T) and Biogen Inc. (BIIB) presented long-term data from the Phase 3 Clarity AD trial showing that continuous treatment with LEQEMBI (lecanemab-irmb) provided sustained benefits in patients with early Alzheimer's disease.
(RTTNews) - BioArctic AB's partner Eisai Co., Ltd. (4523.T) presented long-term data from the Phase 3 Clarity AD trial showing that continuous treatment with LEQEMBI (lecanemab-irmb) provided sustained benefits in patients with early Alzheimer's disease.
(RTTNews) - Cheniere Energy, Inc. (LNG) Monday said that Zach Davis has been appointed President and Chief Financial Officer, or CFO, effective November 12, 2026. The natural gas company said that he had earlier served as Executive Vice President and CFO and will continue to repo
(RTTNews) - European stocks are seen opening on a sluggish note on Tuesday, following more drops for shares in the artificial intelligence industry on Wall Street overnight.
(RTTNews) - Telesat (TSAT, TSAT.TO) announced that Telesat and an ad-hoc committee of holders of Telesat GEO Inc.'s term loans, secured notes, and unsecured notes agreed to standstill arrangements. The lenders will not take any enforcement actions through and including January 18
(RTTNews) - Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company, on Monday announced that its board of directors has approved an additional $5 million share repurchase program.
(RTTNews) - Roche Holding AG (RHHBY) said the U.S. Food and Drug Administration approved Wilserdly, or giredestrant, with everolimus for adults with estrogen receptor-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.
(RTTNews) - Technology One Ltd. (TNE.AX, THNOF), an Australian enterprise software provider, Tuesday reported higher profit and revenues in fiscal 2026. Supported by improved profitability, the firm also lifted dividend. Separately, Technology One announced the appointment of Bri